NewsBenzingaChardan Capital、Vicore Pharma Holdingのカバレッジを開始、投資判断「買い」、目標株価15ドルを発表 Chardan Capital、Vicore Pharma Holdingのカバレッジを開始、投資判断「買い」、目標株価15ドルを発表 Benzinga 2026.11.05 00:26 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Maintains Hold on Skydance, Lowers Price Target to $8.5 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84